MaRS Momentum

À propos du programme

Built for executives who are taking their company to the next level.

Momentum at MaRS - MaRS Discovery District Skip to content --> Skip to content. Jump to Page Footer. Wendy Naimark is the co-founder and chief technology officer at Ripple Therapeutics, a clinical-stage biotech company with a focus on ophthalmology. What We Do Momentum at MaRS Momentum at MaRS Built for executives who are taking their company to the next level. You’ve got a strong team, market traction and big ambitions. But scaling brings new challenges, larger funding rounds, new markets and high-stakes decisions. This program is designed to help your company hit new milestones. Momentum at MaRS provides strategic support to help leaders navigate growth with clarity and confidence. See the companies Between 2020 and 2024 Momentum companies made impact $ 2.7 B total revenue generated $ 3 B in capital raised 9500 + jobs created The Momentum advantage: Strategic support for scaling companies The Momentum program is tailored for leaders of high-growth companies who are navigating new markets, team expansion and strategic plays. It offers: A customized growth plan: Work with tech veterans to build a strategic roadmap that reflects your goals.